Literature DB >> 23679239

Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma.

Xi-Wen Zhu1, Jian-Ping Gong.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) is a member of the immunoglobulin superfamily, its main function being to participate in recognition and adhesion between cells. ICAM-1 is considered closely related to occurrence, development, metastasis and invasion process of hepatocellular carcinoma (HCC). A variety of inflammatory cytokines and stimulus affect its expression through the nuclear factor-kappa B (NF-κB) signal transduction pathway. In the initial stage of inflammation, hepatocirrhosis and tumor development, ICAM-1 is expressed differently, and has varied effects on different cells to promote occurrence of malignancy and metastasis. ICAM-1 has diagnostic significance for AFP-negative or suspected HCC, and may be a prognositic significance. It is thus widely used in studies as a biomarker which reflects cancer cells metastasis as well as curative effect of drugs. Many new treatments of HCC may be based on the effects of ICAM-1 on different levels of function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23679239     DOI: 10.7314/apjcp.2013.14.3.1579

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.

Authors:  Yanqiu Zhang; Mengru Wang; Wanhua Liu; Xin Peng
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

Review 2.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

3.  Role of liver ICAM-1 in metastasis.

Authors:  Aitor Benedicto; Irene Romayor; Beatriz Arteta
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

4.  High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.

Authors:  Peng-Peng Zhu; Sheng-Guang Yuan; Yan Liao; Li-Ling Qin; Wei-Jia Liao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

5.  Soluble intercellular adhesion molecule-1: a potential biomarker for pain intensity in chronic pain patients.

Authors:  Benjamin Luchting; Ludwig Christian Giuseppe Hinske; Banafscheh Rachinger-Adam; Leo Anthony Celi; Simone Kreth; Shahnaz Christina Azad
Journal:  Biomark Med       Date:  2017-02-16       Impact factor: 2.851

6.  Murine MicroRNA-214 regulates intracellular adhesion molecule (ICAM1) gene expression in genital Chlamydia muridarum infection.

Authors:  Tanvi Arkatkar; Rishein Gupta; Weidang Li; Jieh-Juen Yu; Shradha Wali; M Neal Guentzel; James P Chambers; Lane K Christenson; Bernard P Arulanandam
Journal:  Immunology       Date:  2015-06-29       Impact factor: 7.397

7.  Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.

Authors:  Tsung-Po Chen; Hsiang-Lin Lee; Yu-Hui Huang; Ming-Ju Hsieh; Whei-Ling Chiang; Wu-Hsien Kuo; Ming-Chih Chou; Shun-Fa Yang; Chao-Bin Yeh
Journal:  Tumour Biol       Date:  2015-09-05

8.  LPS Up-Regulates ICAM-1 Expression in Breast Cancer Cells by Stimulating a MyD88-BLT2-ERK-Linked Cascade, Which Promotes Adhesion to Monocytes.

Authors:  Geun-Soo Park; Jae-Hong Kim
Journal:  Mol Cells       Date:  2015-08-21       Impact factor: 5.034

9.  STAT3 Target Genes Relevant to Human Cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

10.  FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1 (ICAM-1).

Authors:  Sandeep Chakraborty; David Núñez; Shih-Yang Hu; María Pilar Domingo; Julian Pardo; Artashes Karmenyan; Arthur Chiou
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.